Oncolytics reports positive preclinical data for pelareorep-RAS combo
Go back to Oncolytics reports positive preclinical data for pelareorep-RAS combo| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.88 -0.05 (5.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.93 | 52 Week High | $1.37 | |||
| Open | $0.95 | 52 Week Low | $0.24 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $0.00 | |||
| Volume | 1,558,896 | |||||
